gateway i tp4 housing development fund company, inc.

242 west 36th street 3rd floor
new york, new york 10018

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 03, 2014

NYS DOS ID#
4555718

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2014 - GATEWAY I TP4 HOUSING DEVELOPMENT FUND COMPANY, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • ‘I’d Be Hurt and Upset’: Cities Fear Trump’s Cuts to Urban Programs
    By YAMICHE ALCINDOR - Friday Mar 17, 2017

    President Trump’s proposed cuts to the Department of Housing and Urban Development would eliminate programs cities have used to fund things like Meals on Wheels.

    Source: New York Times
  • Trump Family Wedding Planner to Head New York’s Federal Housing Office
    By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017

    The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.

    Source: NYT > Home Page
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • ‘I Have Stopped Taking My Notebooks and Pens to Meetings’
    By LELA MOORE and JULIA SIMON - Saturday Jun 17, 2017

    Our Top 10 Comments of the Week: Readers debate being interrupted at work, the shooting of a politician and the fate of American “Dreamers.”

    Source: NYT > Home Page
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
    By Frank Vinluan - Tuesday May 30, 2017

    Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]

    Source: Xconomy New York
  • Greater Minnesota Housing Fund Launches Impact Investment Fund
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Thursday Jun 8, 2017

    A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....

    Source: Philanthropy News Digest (PND)
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York